RPRX

Royalty Pharma plc

28.59 USD

Last updated Dec 11, 08:14 UTC

Yesterday HIGH

$28.78

Yesterday LOW

$28.5

52w HIGH

$43.66

52w LOW

$25.92

EPS

0.79

PE

36.19

Next Earnings

Feb 14, 2024

Overview News Insider Transactions Government Trades

Royalty Pharma plc stock is up 5.03% since 30 days ago. The next earnings date is Feb 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 December’s closed higher than November.

Royalty Pharma plc was founded in 1996 and is based in New York, New York. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

royaltypharma.com

Lisa Levin

Thu Jun 29, 2023

$122M Bet On Occidental Petroleum? Check Out These 3 Stocks Insiders Are Buying

Although US stocks closed mixed on Wednesday, there were a few notable insider trades.
Benzinga Insights

Fri Jun 16, 2023

Stocks That Hit 52-Week Lows On Friday

Friday's session saw 32 companies set new 52-week lows.
Benzinga Insights

Thu Jun 15, 2023

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 64 companies achieved new lows for the year.
Lisa Levin

Wed Jun 14, 2023

$10M Bet On GameStop? Check Out These 3 Stocks Insiders Are Buying

Although US stocks closed higher on Tuesday, there were a few notable insider trades.
Benzinga Insights

Wed May 24, 2023

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 129 stocks made new 52-week lows.
Lisa Levin

Thu May 18, 2023

$12.5M Bet On Energy Transfer? Check Out These 4 Stocks Insiders Are Buying

Although US stocks closed higher on Wednesday, there were a few notable insider trades.
Benzinga Newsdesk

Wed May 10, 2023

Morgan Stanley Maintains Overweight on Royalty Pharma, Raises Price Target to $52

Morgan Stanley analyst Terence Flynn maintains Royalty Pharma (NASDAQ:RPRX) with a Overweight and raises the price target from $50 to $52.
Lekha Gupta

Tue May 9, 2023

Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance
Benzinga Newsdesk

Tue May 9, 2023

Royalty Pharma Q1 EPS $1.60 Beats $1.27 Estimate, Sales $684.00M Miss $852.90M Estimate

Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.60 per share which beat the analyst consensus estimate of $1.27 by 25.98 percent. This is a 166.67 percent increase over earnings of $0.60 per share from the
Benzinga Insights

Tue May 9, 2023

Earnings Scheduled For May 9, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.

Legorreta Pablo G., Director

Fri Dec 30, 2022

RPRX Recent Insider Trades and Stock Chart

292,190.49 shares gifted
Legorreta Pablo G., Director

Fri Dec 30, 2022

RPRX Recent Insider Trades and Stock Chart

383,000 shares other